Prasanti Yerramilli
Overview
Explore the profile of Prasanti Yerramilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
438
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Christensen P, Olsen R, Long S, Subedi S, Davis J, Hodjat P, et al.
Am J Pathol
. 2021 Nov;
192(2):320-331.
PMID: 34774517
Genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have repeatedly altered the course of the coronavirus disease 2019 (COVID-19) pandemic. Delta variants are now the focus of intense...
2.
Olsen R, Christensen P, Long S, Subedi S, Hodjat P, Olson R, et al.
Am J Pathol
. 2021 Jul;
191(10):1754-1773.
PMID: 34303698
Certain genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of substantial concern because they may be more transmissible or detrimentally alter the pandemic course and disease features...
3.
Zhu L, Yerramilli P, Pruitt L, Mishra A, Olsen R, Beres S, et al.
J Bacteriol
. 2021 Jun;
203(17):e0023421.
PMID: 34124943
High-molecular-mass penicillin-binding proteins (PBPs) are enzymes that catalyze the biosynthesis of bacterial cell wall peptidoglycan. The Gram-positive bacterial pathogen Streptococcus agalactiae (group B streptococcus [GBS]) produces five high-molecular-mass PBPs, namely,...
4.
Long S, Olsen R, Christensen P, Subedi S, Olson R, Davis J, et al.
Am J Pathol
. 2021 Mar;
191(6):983-992.
PMID: 33741335
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there has been international concern about the emergence of virus variants with mutations that increase transmissibility, enhance...
5.
Long S, Olsen R, Christensen P, Bernard D, Davis J, Shukla M, et al.
mBio
. 2020 Oct;
11(6).
PMID: 33127862
We sequenced the genomes of 5,085 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains causing two coronavirus disease 2019 (COVID-19) disease waves in metropolitan Houston, TX, an ethnically diverse region...
6.
Long S, Olsen R, Christensen P, Bernard D, Davis J, Shukla M, et al.
medRxiv
. 2020 Oct;
PMID: 33024977
We sequenced the genomes of 5,085 SARS-CoV-2 strains causing two COVID-19 disease waves in metropolitan Houston, Texas, an ethnically diverse region with seven million residents. The genomes were from viruses...
7.
Zhu L, Beres S, Yerramilli P, Pruitt L, Cantu C, Olsen R, et al.
J Bacteriol
. 2020 Sep;
202(23).
PMID: 32958630
(group B streptococcus [GBS]) is a major cause of infections in newborns, pregnant women, and immunocompromised patients. GBS strain CNCTC10/84 is a clinical isolate that has high virulence in animal...
8.
Zhu L, Yerramilli P, Pruitt L, Saavedra M, Cantu C, Olsen R, et al.
Infect Immun
. 2020 Aug;
88(10).
PMID: 32747604
(group B streptococcus, or GBS) is a common cause of bacteremia and sepsis in newborns, pregnant women, and immunocompromised patients. The molecular mechanisms used by GBS to survive and proliferate...
9.
Southon S, Beres S, Kachroo P, Saavedra M, Erlendsdottir H, Haraldsson G, et al.
J Clin Microbiol
. 2020 Jun;
58(9).
PMID: 32522827
Resistance to macrolide antibiotics is a global concern in the treatment of (group A [GAS]) infections. In Iceland, since the detection of the first macrolide-resistant isolate in 1998, three epidemic...
10.
Salazar E, Perez K, Ashraf M, Chen J, Castillo B, Christensen P, et al.
medRxiv
. 2020 Jun;
PMID: 32511574
Background: COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally, and no proven treatments are available. Convalescent plasma therapy has been used with varying degrees...